Sodium metabisulfite (E223)

This is the clearest human signal. Oral and inhalation challenge studies, plus long-standing clinical reviews, show that a minority of people with asthma can develop reproducible bronchoconstriction after sulfite exposure, including sodium metabisulfite. Older challenge literature often places the prevalence somewhere around the low single digits to about 10% of chronic asthmatics, with higher risk in more severe or steroid-dependent asthma. That makes the concern real, but it is still a subgroup issue rather than a universal response.

This is where the public conversation often gets too simple. In blinded and cumulative challenge studies, many people who report wine-triggered asthma or suspected sulfite reactions do not show a clear reproducible response under test conditions, and some only react at relatively high sulfite concentrations. That suggests sulfites explain some reactions, but not all of them, and that other wine components or cofactors may matter too.

Older oral-challenge studies in chronic urticaria and angioedema found occasional positive reactions to sodium metabisulfite, which is why allergists still consider sulfites when patients report reproducible reactions to packaged foods or drinks. But challenge-confirmed cases appear uncommon, and many self-suspected additive reactions do not hold up cleanly under formal testing. So the possibility is real, just not common enough to treat sulfites as a default explanation for unexplained hives.

Case reports and older reviews describe rare severe reactions, including anaphylaxis-like presentations, after sulfite exposure. That is one reason undeclared sulfites are taken seriously in labeling and recalls. But the evidence here is mostly case-based rather than built on large modern prospective datasets, so it supports caution for known-sensitive individuals more than broad fear for everyone else.

Patch-test series and case reports show sodium metabisulfite can be a relevant contact allergen, particularly in hairdressing, food handling, cosmetics, and pharmaceutical settings. That route matters because skin or workplace exposure is different from ordinary eating. For someone with hand eczema or recurrent facial dermatitis linked to specific products or tasks, sodium metabisulfite is more plausible than it is as a general dietary skin-harm explanation.

A lot of alarming sodium-metabisulfite content online leans on cell studies, animal experiments, or high-dose toxicology findings. Those papers can raise legitimate hypotheses about oxidative stress or cytotoxicity, but they do not amount to strong human evidence that ordinary dietary exposure clearly causes cancer or chronic disease on its own. At the moment, the human literature is much stronger for acute sensitivity reactions than for sweeping long-term disease claims.

This is the context claim most readers need. Sodium metabisulfite turns up in foods and products with very different health profiles, from dried fruit and shrimp to wine, processed potato products, and some medicines. For most people, the bigger determinants of health are still the overall diet pattern, alcohol intake, calorie balance, and how much ultra-processed food they rely on. But if you already know you are sulfite-sensitive, the context flips: even a small exposure can matter more to you than the rest of the category label suggests.